Intralesional administration of I-131 labelled monoclonal antibodies in the treatment of malignant gliomas View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1995-09

AUTHORS

A. Arista, C. Sturiale, P. Riva, V. Tison, M. Frattarelli, G. Moscatelli, G. Franceschi, A. Spinelli

ABSTRACT

The authors report their preliminary experience with the use of radiolabelled monoclonal antibodies (MAb) as an adjuvant treatment for 33 malignant gliomas. MAbs employed in this study are raised against Tenascin (TN) which is an antigen of the extracellular matrix of the tumour. It has also been found in neoplastic cells but never in normal brain tissue. This therapy is aimed to give a local high dose radiation (boost) while sparing healthy brain structures.This treatment has always been well tolerated and no adverse reactions at the level of CNS or major extraneural organs has been observed. Significant improvement of median survival has been obtained but this result should be cautiously evaluate since the study is non-randomized. Comparison with other current adjuvant technique is briefly discussed. More... »

PAGES

159-162

References to SciGraph publications

  • 1975-08. Continuous cultures of fused cells secreting antibody of predefined specificity in NATURE
  • 1992. Radiosurgery in ADVANCES AND TECHNICAL STANDARDS IN NEUROSURGERY
  • 1986-10. Radioimmunolocalisation of human brain tumours: Biodistribution of radiolabelled monoclonal antibody UJ13A in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/bf02187762

    DOI

    http://dx.doi.org/10.1007/bf02187762

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1042591080

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/8748808


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Astrocytoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Brain", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Brain Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Combined Modality Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Diagnostic Imaging", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Follow-Up Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glioblastoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Injections, Intralesional", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Iodine Radioisotopes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm, Residual", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Radioimmunotherapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Radiotherapy, Adjuvant", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tenascin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Neurosurgery Department, Hospital Cesena, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Neurosurgery Department, Hospital Cesena, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Arista", 
            "givenName": "A.", 
            "id": "sg:person.0722464216.62", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722464216.62"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Neurosurgery Department, Hospital Cesena, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Neurosurgery Department, Hospital Cesena, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sturiale", 
            "givenName": "C.", 
            "id": "sg:person.0707212772.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707212772.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Riva", 
            "givenName": "P.", 
            "id": "sg:person.01177547630.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177547630.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pathology Service \u201cM. Bufalini\u201d, Hospital Cesena, Italy", 
              "id": "http://www.grid.ac/institutes/grid.414682.d", 
              "name": [
                "Pathology Service \u201cM. Bufalini\u201d, Hospital Cesena, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tison", 
            "givenName": "V.", 
            "id": "sg:person.01255126264.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255126264.90"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Neurosurgery Department, Hospital Cesena, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Neurosurgery Department, Hospital Cesena, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Frattarelli", 
            "givenName": "M.", 
            "id": "sg:person.01322326452.21", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322326452.21"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Moscatelli", 
            "givenName": "G.", 
            "id": "sg:person.01212250304.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212250304.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Franceschi", 
            "givenName": "G.", 
            "id": "sg:person.01371354664.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371354664.54"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Spinelli", 
            "givenName": "A.", 
            "id": "sg:person.01105600202.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105600202.52"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/256495a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001387921", 
              "https://doi.org/10.1038/256495a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-3-7091-6672-7_2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042312345", 
              "https://doi.org/10.1007/978-3-7091-6672-7_2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00263810", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022848260", 
              "https://doi.org/10.1007/bf00263810"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1995-09", 
        "datePublishedReg": "1995-09-01", 
        "description": "The authors report their preliminary experience with the use of radiolabelled monoclonal antibodies (MAb) as an adjuvant treatment for 33 malignant gliomas. MAbs employed in this study are raised against Tenascin (TN) which is an antigen of the extracellular matrix of the tumour. It has also been found in neoplastic cells but never in normal brain tissue. This therapy is aimed to give a local high dose radiation (boost) while sparing healthy brain structures.This treatment has always been well tolerated and no adverse reactions at the level of CNS or major extraneural organs has been observed. Significant improvement of median survival has been obtained but this result should be cautiously evaluate since the study is non-randomized. Comparison with other current adjuvant technique is briefly discussed.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/bf02187762", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1412990", 
            "issn": [
              "0001-6268", 
              "0942-0940"
            ], 
            "name": "Acta Neurochirurgica", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3-4", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "135"
          }
        ], 
        "keywords": [
          "monoclonal antibodies", 
          "malignant gliomas", 
          "radiolabelled monoclonal antibodies", 
          "high-dose radiation", 
          "normal brain tissue", 
          "adjuvant treatment", 
          "median survival", 
          "intralesional administration", 
          "extraneural organs", 
          "adverse reactions", 
          "adjuvant techniques", 
          "neoplastic cells", 
          "preliminary experience", 
          "brain tissue", 
          "brain structures", 
          "dose radiation", 
          "gliomas", 
          "treatment", 
          "antibodies", 
          "significant improvement", 
          "tenascin", 
          "extracellular matrix", 
          "therapy", 
          "tumors", 
          "antigen", 
          "administration", 
          "survival", 
          "levels of CN", 
          "organs", 
          "study", 
          "tissue", 
          "cells", 
          "CN", 
          "levels", 
          "improvement", 
          "experience", 
          "use", 
          "comparison", 
          "authors", 
          "results", 
          "radiation", 
          "reaction", 
          "technique", 
          "matrix", 
          "structure"
        ], 
        "name": "Intralesional administration of I-131 labelled monoclonal antibodies in the treatment of malignant gliomas", 
        "pagination": "159-162", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1042591080"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/bf02187762"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "8748808"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/bf02187762", 
          "https://app.dimensions.ai/details/publication/pub.1042591080"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-20T07:20", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_305.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/bf02187762"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf02187762'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf02187762'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf02187762'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf02187762'


     

    This table displays all metadata directly associated to this object as RDF triples.

    257 TRIPLES      22 PREDICATES      96 URIs      85 LITERALS      28 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/bf02187762 schema:about N0607ec282e9a414582a38adb90f8d8ac
    2 N0fba58e814064513a28ed4a09e02a544
    3 N1f00d5c9cc8747f5936808078f86286e
    4 N2d10548cde2b4548b76fafbbf75e3295
    5 N3966b5ab0a6e4856978b800ec1ddd6ba
    6 N3fa243ab302542d1861fb89375b4d41a
    7 N4a993dda20644c14a70a9f4dcb3939f2
    8 N551dc8a448a649b4853dc079ab73c9ee
    9 N5b475dc7aba84ffbb91c29247fbc8259
    10 N6fc5c6d7262f4f53906fcda08b2b2f2b
    11 N70516056e4314175b84a8772c8b2f08c
    12 N82e97843f6544e4ea96d3bf9e8caba6d
    13 N898ea4e309db44bfbff498e3ce707411
    14 N89eff12f5ce746879a216cb89f998a5d
    15 Nbbfc50dac0f44231b50f9f7ef7ced6e7
    16 Nbf7d51cfb4ff4ed4a8fb6821875ee8fb
    17 Nc4330bd668544cb5b260f43afd7ba839
    18 Ncbde9ebc4db047628c144610fabe00ba
    19 Nd751144afe594fd9bf31adcae8211b40
    20 Ne167aa288c52462e97f6621d0365f9dd
    21 Ne852ba4f0bd648d4b634ea932150b0c4
    22 anzsrc-for:11
    23 anzsrc-for:1112
    24 schema:author N8ec64e7bb514459a8a885746f41e3b03
    25 schema:citation sg:pub.10.1007/978-3-7091-6672-7_2
    26 sg:pub.10.1007/bf00263810
    27 sg:pub.10.1038/256495a0
    28 schema:datePublished 1995-09
    29 schema:datePublishedReg 1995-09-01
    30 schema:description The authors report their preliminary experience with the use of radiolabelled monoclonal antibodies (MAb) as an adjuvant treatment for 33 malignant gliomas. MAbs employed in this study are raised against Tenascin (TN) which is an antigen of the extracellular matrix of the tumour. It has also been found in neoplastic cells but never in normal brain tissue. This therapy is aimed to give a local high dose radiation (boost) while sparing healthy brain structures.This treatment has always been well tolerated and no adverse reactions at the level of CNS or major extraneural organs has been observed. Significant improvement of median survival has been obtained but this result should be cautiously evaluate since the study is non-randomized. Comparison with other current adjuvant technique is briefly discussed.
    31 schema:genre article
    32 schema:inLanguage en
    33 schema:isAccessibleForFree false
    34 schema:isPartOf N20597ce4ce6f46b7a7068a1a9cf94a9e
    35 Nf689ad2fd7a644fc8d271a099b609c60
    36 sg:journal.1412990
    37 schema:keywords CN
    38 adjuvant techniques
    39 adjuvant treatment
    40 administration
    41 adverse reactions
    42 antibodies
    43 antigen
    44 authors
    45 brain structures
    46 brain tissue
    47 cells
    48 comparison
    49 dose radiation
    50 experience
    51 extracellular matrix
    52 extraneural organs
    53 gliomas
    54 high-dose radiation
    55 improvement
    56 intralesional administration
    57 levels
    58 levels of CN
    59 malignant gliomas
    60 matrix
    61 median survival
    62 monoclonal antibodies
    63 neoplastic cells
    64 normal brain tissue
    65 organs
    66 preliminary experience
    67 radiation
    68 radiolabelled monoclonal antibodies
    69 reaction
    70 results
    71 significant improvement
    72 structure
    73 study
    74 survival
    75 technique
    76 tenascin
    77 therapy
    78 tissue
    79 treatment
    80 tumors
    81 use
    82 schema:name Intralesional administration of I-131 labelled monoclonal antibodies in the treatment of malignant gliomas
    83 schema:pagination 159-162
    84 schema:productId N04d9ae55dc1443159aba94848c995061
    85 N1243aa4f8f264d29a064c3e3ffb450e8
    86 N276e2bc0f97e44f99631d157904adf55
    87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042591080
    88 https://doi.org/10.1007/bf02187762
    89 schema:sdDatePublished 2022-05-20T07:20
    90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    91 schema:sdPublisher Nf2b49396a95d4530bbd40a99cf146b38
    92 schema:url https://doi.org/10.1007/bf02187762
    93 sgo:license sg:explorer/license/
    94 sgo:sdDataset articles
    95 rdf:type schema:ScholarlyArticle
    96 N04d9ae55dc1443159aba94848c995061 schema:name doi
    97 schema:value 10.1007/bf02187762
    98 rdf:type schema:PropertyValue
    99 N0607ec282e9a414582a38adb90f8d8ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    100 schema:name Brain Neoplasms
    101 rdf:type schema:DefinedTerm
    102 N08b80e89788048189f634db611602043 rdf:first sg:person.01212250304.38
    103 rdf:rest Nd6da264cd5734358a3a00fc253925552
    104 N0fba58e814064513a28ed4a09e02a544 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    105 schema:name Middle Aged
    106 rdf:type schema:DefinedTerm
    107 N1243aa4f8f264d29a064c3e3ffb450e8 schema:name pubmed_id
    108 schema:value 8748808
    109 rdf:type schema:PropertyValue
    110 N1f00d5c9cc8747f5936808078f86286e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    111 schema:name Radioimmunotherapy
    112 rdf:type schema:DefinedTerm
    113 N20597ce4ce6f46b7a7068a1a9cf94a9e schema:issueNumber 3-4
    114 rdf:type schema:PublicationIssue
    115 N25715bee36a344bfa4dea944cacb3254 rdf:first sg:person.01322326452.21
    116 rdf:rest N08b80e89788048189f634db611602043
    117 N276e2bc0f97e44f99631d157904adf55 schema:name dimensions_id
    118 schema:value pub.1042591080
    119 rdf:type schema:PropertyValue
    120 N2d10548cde2b4548b76fafbbf75e3295 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Aged
    122 rdf:type schema:DefinedTerm
    123 N3966b5ab0a6e4856978b800ec1ddd6ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    124 schema:name Injections, Intralesional
    125 rdf:type schema:DefinedTerm
    126 N3fa243ab302542d1861fb89375b4d41a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Combined Modality Therapy
    128 rdf:type schema:DefinedTerm
    129 N4a993dda20644c14a70a9f4dcb3939f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    130 schema:name Male
    131 rdf:type schema:DefinedTerm
    132 N551dc8a448a649b4853dc079ab73c9ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    133 schema:name Neoplasm, Residual
    134 rdf:type schema:DefinedTerm
    135 N5b475dc7aba84ffbb91c29247fbc8259 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    136 schema:name Treatment Outcome
    137 rdf:type schema:DefinedTerm
    138 N6fc5c6d7262f4f53906fcda08b2b2f2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name Brain
    140 rdf:type schema:DefinedTerm
    141 N70516056e4314175b84a8772c8b2f08c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Tenascin
    143 rdf:type schema:DefinedTerm
    144 N7d474f2e389f42b6b349bf8879772f59 rdf:first sg:person.0707212772.14
    145 rdf:rest N7f070c3f484c484c8bd485049f2653ce
    146 N7f070c3f484c484c8bd485049f2653ce rdf:first sg:person.01177547630.17
    147 rdf:rest N9119594bbbf441bea78f74749e2f05c1
    148 N82e97843f6544e4ea96d3bf9e8caba6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Adult
    150 rdf:type schema:DefinedTerm
    151 N898ea4e309db44bfbff498e3ce707411 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Astrocytoma
    153 rdf:type schema:DefinedTerm
    154 N89eff12f5ce746879a216cb89f998a5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Iodine Radioisotopes
    156 rdf:type schema:DefinedTerm
    157 N8ec64e7bb514459a8a885746f41e3b03 rdf:first sg:person.0722464216.62
    158 rdf:rest N7d474f2e389f42b6b349bf8879772f59
    159 N9119594bbbf441bea78f74749e2f05c1 rdf:first sg:person.01255126264.90
    160 rdf:rest N25715bee36a344bfa4dea944cacb3254
    161 Nbbfc50dac0f44231b50f9f7ef7ced6e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Humans
    163 rdf:type schema:DefinedTerm
    164 Nbf7d51cfb4ff4ed4a8fb6821875ee8fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Antibodies, Monoclonal
    166 rdf:type schema:DefinedTerm
    167 Nc4330bd668544cb5b260f43afd7ba839 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    168 schema:name Diagnostic Imaging
    169 rdf:type schema:DefinedTerm
    170 Ncbde9ebc4db047628c144610fabe00ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Follow-Up Studies
    172 rdf:type schema:DefinedTerm
    173 Nd6da264cd5734358a3a00fc253925552 rdf:first sg:person.01371354664.54
    174 rdf:rest Nf5dd1efbfca7492da641e4ded3490194
    175 Nd751144afe594fd9bf31adcae8211b40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Female
    177 rdf:type schema:DefinedTerm
    178 Ne167aa288c52462e97f6621d0365f9dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    179 schema:name Radiotherapy, Adjuvant
    180 rdf:type schema:DefinedTerm
    181 Ne852ba4f0bd648d4b634ea932150b0c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Glioblastoma
    183 rdf:type schema:DefinedTerm
    184 Nf2b49396a95d4530bbd40a99cf146b38 schema:name Springer Nature - SN SciGraph project
    185 rdf:type schema:Organization
    186 Nf5dd1efbfca7492da641e4ded3490194 rdf:first sg:person.01105600202.52
    187 rdf:rest rdf:nil
    188 Nf689ad2fd7a644fc8d271a099b609c60 schema:volumeNumber 135
    189 rdf:type schema:PublicationVolume
    190 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    191 schema:name Medical and Health Sciences
    192 rdf:type schema:DefinedTerm
    193 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    194 schema:name Oncology and Carcinogenesis
    195 rdf:type schema:DefinedTerm
    196 sg:journal.1412990 schema:issn 0001-6268
    197 0942-0940
    198 schema:name Acta Neurochirurgica
    199 schema:publisher Springer Nature
    200 rdf:type schema:Periodical
    201 sg:person.01105600202.52 schema:affiliation grid-institutes:None
    202 schema:familyName Spinelli
    203 schema:givenName A.
    204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105600202.52
    205 rdf:type schema:Person
    206 sg:person.01177547630.17 schema:affiliation grid-institutes:None
    207 schema:familyName Riva
    208 schema:givenName P.
    209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177547630.17
    210 rdf:type schema:Person
    211 sg:person.01212250304.38 schema:affiliation grid-institutes:None
    212 schema:familyName Moscatelli
    213 schema:givenName G.
    214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212250304.38
    215 rdf:type schema:Person
    216 sg:person.01255126264.90 schema:affiliation grid-institutes:grid.414682.d
    217 schema:familyName Tison
    218 schema:givenName V.
    219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255126264.90
    220 rdf:type schema:Person
    221 sg:person.01322326452.21 schema:affiliation grid-institutes:None
    222 schema:familyName Frattarelli
    223 schema:givenName M.
    224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322326452.21
    225 rdf:type schema:Person
    226 sg:person.01371354664.54 schema:affiliation grid-institutes:None
    227 schema:familyName Franceschi
    228 schema:givenName G.
    229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371354664.54
    230 rdf:type schema:Person
    231 sg:person.0707212772.14 schema:affiliation grid-institutes:None
    232 schema:familyName Sturiale
    233 schema:givenName C.
    234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707212772.14
    235 rdf:type schema:Person
    236 sg:person.0722464216.62 schema:affiliation grid-institutes:None
    237 schema:familyName Arista
    238 schema:givenName A.
    239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722464216.62
    240 rdf:type schema:Person
    241 sg:pub.10.1007/978-3-7091-6672-7_2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042312345
    242 https://doi.org/10.1007/978-3-7091-6672-7_2
    243 rdf:type schema:CreativeWork
    244 sg:pub.10.1007/bf00263810 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022848260
    245 https://doi.org/10.1007/bf00263810
    246 rdf:type schema:CreativeWork
    247 sg:pub.10.1038/256495a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001387921
    248 https://doi.org/10.1038/256495a0
    249 rdf:type schema:CreativeWork
    250 grid-institutes:None schema:alternateName Neurosurgery Department, Hospital Cesena, Italy
    251 Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy
    252 schema:name Neurosurgery Department, Hospital Cesena, Italy
    253 Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy
    254 rdf:type schema:Organization
    255 grid-institutes:grid.414682.d schema:alternateName Pathology Service “M. Bufalini”, Hospital Cesena, Italy
    256 schema:name Pathology Service “M. Bufalini”, Hospital Cesena, Italy
    257 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...